oalib

OALib Journal期刊

ISSN: 2333-9721

费用:99美元

投稿

时间不限

( 2673 )

( 2024 )

( 2023 )

( 2022 )

自定义范围…

匹配条件: “Su Hyeon Jung” ,找到相关结果约29416条。
列表显示的所有文章,均可免费获取
第1页/共29416条
每页显示
Immediate balloon deflation method in endoscopic papillary large balloon dilation for extraction of difficult bile duct stones  [PDF]
Duk Joo Choi, Yeon Suk Kim, Jung Ho Kim, Yang Suh Ku, Min Su Ha, Ju Hyeon Kim
Open Journal of Gastroenterology (OJGas) , 2013, DOI: 10.4236/ojgas.2013.32024
Abstract:

Background/Aims: Recently, endoscopic papillary large balloon dilation (EPLBD) using a large balloon (12 - 20 mm) for extraction of difficult common bile duct (CBD) stones has been widely accepted with favorable outcomes. However, there is no consensus with regard to the ballooning time. The aim of our study was to evaluate the efficacy and safety of immediate balloon deflation in EPLBD for the treatment of difficult bile duct stone. Methods: This was a retrospective study of 80 consecutive patients with bile duct stones who were treated with an immediate balloon deflation method in EPLBD combined with endoscopic sphincterotomy (EST) between January 2010 and December 2012. Overall success rate, success rate at first ERCP, and the frequency of mechanical lithotripsy for complete stone removal were assessed for efficacy and safety was evaluated by assessing major complications. Results: Overall success rate for complete stone removal was high (78/80, 97.5%) and success rate for complete stone removal at first ERCP was 86.3% (69/80). The use of mechanical lithotripsy was 0% (0/80). The overall complication rate was favorable (5/80, 6.3%). PostERCP pancreatitis was observed in 3 patients (two: mild, one: moderate). In subgroup analysis, the presence of periampullary diverticulum was the only factor affecting the success rate at first ERCP. Conclusion: This study demonstrated the favorable outcome of immediate balloon deflation for treatment of difficult CBD stones and can be considered for clinical application.

Aggressive Multimodal Approach for Anaplastic Thyroid Cancer and Long-Term Survival
Nasir Hussain,Usman Mustafa,Su Hyeon Jung,Alan D. Gilman
Case Reports in Oncological Medicine , 2013, DOI: 10.1155/2013/783862
Abstract:
Aggressive Multimodal Approach for Anaplastic Thyroid Cancer and Long-Term Survival
Nasir Hussain,Usman Mustafa,Su Hyeon Jung,Alan D. Gilman
Case Reports in Oncological Medicine , 2013, DOI: 10.1155/2013/783862
Abstract: Anaplastic thyroid cancer (ATC) comprises 1-2% of all thyroid cancers and is one of the most aggressive cancers with a median survival rate of around four months. The average 5-year survival rate has been reported to be around 3.6%. In this paper, we have discussed management and prognostic variables of a patient with ATC who has survived for more than 5 years. A 59-year-old female was referred to our facility for an elective thyroid and parathyroidectomy for concerns of thyroid papillary cancer and hyperparathyroidism. At the time of surgery, the tumor mass had invaded the muscular layer of esophagus; radicle thyroidectomy parathyroidectomy along with removal of muscle layer of esophagus was performed, and diagnosis of ATC was made. The patient was treated with chemoradiation with a good treatment response and no recurrence of tumor for two and a half years until PET/CT followed by wedge biopsy of lung confirmed ATC recurrence. The patient was treated with another course of radiation treatment with a good treatment response. Since then, the patient has been following in our outpatient oncology clinic and has no evidence of tumor recurrence. Aggressive multimodal approach of combining radicle surgery with chemoradiation treatment in select patients of ATC with no distant metastasis helps improve prognosis. 1. Introduction Anaplastic thyroid cancer (ATC) comprises 1-2% of all thyroid cancers and is one of the most aggressive cancers with a median survival rate of a few months [1]. ATC contributes up to 14–50% of the annual mortality due to thyroid cancer [2]. The average 5-year survival rate for ATC is around 3.6% [3]. In this paper, we describe treatment course of a patient who has survived for more than five years following the diagnosis of ATC. We have also provided concise review of the prognostic variables that affect the outcome in cases of ATC. 2. Case Presentation A 59-year-old female with a past medical history of breast cancer (status after radiation therapy (RT) and a subsequent mastectomy for tumor recurrence), osteoporosis, and hypercalcemia was referred for elective thyroid and parathyroidectomy. The patient had a thyroid lump for months which on imaging (PET CT scan) and ultrasound guided biopsy was found to be a papillary cancer with no distant metastasis (two weeks prior to the presentation). A parathyroid localization scan one day prior to the presentation was suggestive of parathyroid adenomas. At the time of presentation, vital signs, physical examination, and basic diagnostic lab test including complete blood count, comprehensive
Anemia is associated with incidence of dementia: a national health screening study in Korea involving 37,900 persons
Ji Eun Lee,Jinkook Lee,Jung Hyeon Hyeon,SangYun Kim,Su-Min Jeong
- , 2017, DOI: 10.1186/s13195-017-0322-2
Abstract: The online version of this article (doi:10.1186/s13195-017-0322-2) contains supplementary material, which is available to authorized users
Second-line glucose-lowering drugs added to metformin and the risk of hospitalization for heart failure: A nationwide cohort study
Dae Jung Kim,Hokyou Lee,Hyeon Chang Kim,Jung Hyun Lee,Kyoung Hwa Ha,Su Jin Lee
- , 2019, DOI: 10.1371/journal.pone.0211959
Abstract:
Sarcoidosis Associated with Oxaliplatin-Based Chemotherapy for Colorectal Cancer
Ji Hoon Choi,Jung A. Shin,Hye Kyeong Park,Su Young Kim,Hoon Jung,Sung-Soon Lee,Hye Ran Lee,Hyeon-Kyoung Koo
Case Reports in Oncological Medicine , 2014, DOI: 10.1155/2014/203027
Abstract: Acute lung injury occasionally occurs after chemotherapy, but pulmonary toxicities by oxaliplatin-based chemotherapy have rarely been identified. A 76-year-old female with rectosigmoid colon cancer presented with ongoing dyspnea after the eighth cycle of standard chemotherapy (5-fluorouracil, sodium folinic acid, and oxaliplatin: FOLFOX). Nodular consolidation progressed despite antibiotics and BAL fluid analysis was compatible with the diagnosis of sarcoidosis. Corticosteroid therapy rapidly improved the symptoms and radiographic findings. We report this first case of secondary sarcoidosis related to FOLFOX therapy with review of references. 1. Introduction The standard palliative treatment for patients with advanced or metastatic colorectal cancer, consisting of oxaliplatin or irinotecan and 5-fluorouracil (5-FU) based chemotherapy, can extend patient’s survival up to 22 months [1–3]. The usual adverse effects following these regimens are hematological (13–52%), gastrointestinal (10–33%), and neurological (0–8%) toxicities [4]. However despite the widespread application of this regimen, pulmonary toxicities of oxaliplatin-based chemotherapy are rarely reported. We recently observed a rare case of secondary sarcoidosis related to oxaliplatin-based chemotherapy that presented as progressive dyspnea. 2. Case Report A 76-year-old female never-smoker visited our hospital because of progressive dyspnea beginning one month ago. She had been diagnosed with rectosigmoid colon adenocarcinoma and had undergone low anterior resection and a total abdominal hysterectomy with bilateral salpingo-oophorectomy 8 months previously. Her surgical stage was T4bN0 because of direct invasion into the left ovary, but the initial computed tomography (CT) showed small uncertain nodules in liver and lung. After a second cycle of adjuvant 5-fluorouracil with leucovorin, positron-emission tomography (PET-CT) scan showed progression of liver metastasis with FDG-uptake (SUV 8.4), but the lung nodules in the left upper lobe were stable and without FDG-uptake. The chemotherapy regimen was changed to 5-fluorouracil, leucovorin, and oxaliplatin (FOLFOX) and infused every other week without significant adverse events. After the fourth cycle of FOLFOX regimen, asymptomatic pulmonary embolism was detected and anticoagulation with warfarin had started. At completion of the eighth cycle, she complained of progressive dyspnea without other respiratory symptoms. In PET-CT, the size of previous pulmonary nodules had been decreased, but several other ill-defined nodules that showed FDG-uptake
Revisiting Primary Particles in Layered Lithium Transition‐Metal Oxides and Their Impact on Structural Degradation
Changhoon Jung,Dong‐Su Ko,Gyeong‐Su Park,Hee Goo Kim,Seong‐Hyeon Hong,Seong‐Yong Park,Seung‐Yong Lee,Yimei Zhu
- , 2019, DOI: 10.1002/advs.201800843
Abstract: Layered lithium transition‐metal oxide materials, e.g., Li(Ni1? x ? yCoxMny)O2 (NCM) and Li(Ni1? x ? yCoxAly)O2, are the most promising candidates for lithium‐ion battery cathodes. They generally consist of ≈10 μm spherical particles densely packed with smaller particles (0.1–1 μm), called secondary and primary particles, respectively. The micrometer‐ to nanometer‐sized particles are critical to the battery performance because they affect the reaction capability of the cathode. Herein, the crystal structure of the primary particles of NCM materials is revisited. Elaborate transmission electron microscopy investigations reveal that the so‐called primary particles, often considered as single crystals, are in fact polycrystalline secondary particles. They contain low‐angle and exceptionally stable special grain boundaries (GBs) presumably created during aggregation via an oriented attachment mechanism. Therefore, this so‐called primary particle is renamed as primary‐like particle. More importantly, the low‐angle GBs between the smaller true primary particles cause the development of nanocracks within the primary‐like particles of Ni‐rich NCM cathodes after repetitive electrochemical cycles. In addition to rectifying a prevalent misconception about primary particles, this study provides a previously unknown but important origin of structural degradation in Ni‐rich layered cathodes
Phytoestrogen Enriched Tofu from Soybean Meal  [PDF]
Su Hyeon Hwang, Pushparajah Thavarajah, Dilrukshi Thavarajah
American Journal of Plant Sciences (AJPS) , 2014, DOI: 10.4236/ajps.2014.53034
Abstract:

Isoflavone, a group of phytoestrogen, reduces postmenopausal symptoms and the risk of osteoporosis of women. Glycosidic forms of isoflavones are presented in non-fermented soyfoods such as tofu and they are less bioavailable than the aglycone isoflavones. Aglycone forms of isoflavones or more bioavailable forms can be increased by acid hydrolysis during tofu processing. The present study investigated the possibility of increasing the aglycone forms of isoflavones by acid hydrolysis. We used five types of tofu in this study: soybean tofu with hydrolysis, soybean meal tofu with hydrolysis, soybean tofu in general process, soybean meal tofu in general process, and commercial tofu. Defatted soybean meal was used as the major ingredient in the tofu which was made by using the new method—acid hydrolysis. To identify the isoflavone quantities in all five types of tofu, high performance liquid chromatography with diode array detection (HPLC-DAD) analysis was employed. The genistein ratio between hydrolyzed tofu and standard tofu was 1:1-8, and the daidzein ratio between hydrolyzed tofu and standard tofu was 1:6-12. The five types of tofu were analyzed for the crude protein and micronutrients such as calcium (Ca), magnesium (Mg), potassium (K), iron (Fe), zinc (Zn), and selenium (Se) by the modified Kjeldahl method and inductively coupled plasma emission spectroscopy (ICP-ES), respectively. The mean crude protein concentration of hydrolyzed tofu

Robotic-assisted laparoscopic myomectomy: the feasibility in single-site system
Bo Seong Yun,Hyo Sook Bae,Mi Kyoung Kim,Mi-La Kim,Miseon Kim,Seok Ju Seong,Soyeon Hong,Su Hyeon Choi,Yong Wook Jung
- , 2019, DOI: 10.5468/ogs.2019.62.1.56
Abstract: To evaluate the feasibility of robotic single-site myomectomy (RSSM)
The effect of high glucose levels on the hypermethylation of protein phosphatase 1 regulatory subunit 3C (PPP1R3C) gene in colorectal cancer
Hyeon Soo Kim,Ji Wook Moon,Jin Kim,Jung Ok Lee,Nami Kim,Soo Kyung Lee,Su Jin Kim,Sun-Hwa Park,Yong Woo Lee
- , 2015,
Abstract:
第1页/共29416条
每页显示


Home
Copyright © 2008-2020 Open Access Library. All rights reserved.